Stay updated on Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial page.

Latest updates to the Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial page
- Check6 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.2 to v3.8.0, with the study history content unchanged.SummaryDifference0.1%

- Check13 days agoChange DetectedA notice was added announcing NIH website updates and explaining that some content will use “Super Intelligence” (SI) instead of “Artificial Intelligence” (AI) during the transition.SummaryDifference0.5%

- Check19 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2, with no change to the study record content.SummaryDifference0.1%

- Check26 days agoChange DetectedThe ClinicalTrials.gov footer version label advances from v3.7.0 to v3.7.1; the clinical trial record content is unchanged.SummaryDifference0.1%

- Check47 days agoChange DetectedA new revision entry v3.7.0 was added to the record history, and the previous revision v3.6.6 was removed. This reflects a software or UI update affecting how the page tracks changes rather than changes to the study data.SummaryDifference0.1%

- Check69 days agoChange DetectedA new revision entry labeled v3.6.6 has been added to the study's record history, indicating an updated version of the record. The previous revision v3.6.5 is removed from the visible history.SummaryDifference0.1%

Stay in the know with updates to Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Efsitora Alfa vs Insulin Degludec in Type 1 Diabetes Clinical Trial page.